Zumbro Discovery

About:

Zumbro is a biotechnology company committed to the clinical development of novel peptides for cardiovascular and metabolic disease.

Website: http://zumbrodiscovery.com/

Top Investors: Broadview Ventures

Description:

Zumbro Discovery, Inc. is developing a novel natriuretic peptide, MANP, for the treatment of resistant hypertension for which there is an unmet medical need for a syndrome which increases risk for heart failure, myocardial infarction, stroke and kidney disease. MANP was discovered at the Mayo Clinic and is soon entering first in human studies.